---
title: "aTyr Pharma (ATYR) Receives a Hold from Wells Fargo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286079436.md"
description: "Wells Fargo analyst Derek Archila has maintained a Hold rating on aTyr Pharma (ATYR) with a price target of $1.00, while the shares closed at $0.95. Archila, a 5-star analyst, has an average return of 20.1% and a 53.67% success rate. The current analyst consensus for aTyr Pharma is also a Hold, with an average price target of $7.33."
datetime: "2026-05-12T10:26:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286079436.md)
  - [en](https://longbridge.com/en/news/286079436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286079436.md)
---

# aTyr Pharma (ATYR) Receives a Hold from Wells Fargo

Wells Fargo analyst Derek Archila maintained a Hold rating on aTyr Pharma yesterday and set a price target of $1.00. The company’s shares closed yesterday at $0.95.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Archila is a 5-star analyst with an average return of 20.1% and a 53.67% success rate. Archila covers the Healthcare sector, focusing on stocks such as Rhythm Pharmaceuticals, Argenx Se, and Disc Medicine.

Currently, the analyst consensus on aTyr Pharma is a Hold with an average price target of $7.33.

### Related Stocks

- [ATYR.US](https://longbridge.com/en/quote/ATYR.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [RYTM.US](https://longbridge.com/en/quote/RYTM.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [IRON.US](https://longbridge.com/en/quote/IRON.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)](https://longbridge.com/en/news/286843768.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [This Analyst Just Downgraded Their EQL Pharma AB (publ) (STO:EQL) EPS Forecasts](https://longbridge.com/en/news/286365780.md)
- [Earnings Beat: Odfjell Drilling Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286515920.md)